IDEA GENERATION

Lithium, Specialty Chemicals & Specialty Fertilizers

Long/Short Stock Screening & Value-Chain Sweep — Focus: SQM

2026-04-28

1. Quantitative Screens

We screened the global lithium and specialty-chemicals universe using five complementary lenses to identify both long and short candidates after the 2024-2025 lithium price collapse: (1) Value — pure-plays and integrated producers trading at trough multiples with positive FCF and manageable leverage; (2) Growth — emerging producers with capacity ramp visibility through 2028 and balance-sheet capability; (3) Quality — lowest-decile cost producers with through-cycle profitability; (4) Short — over-levered, marginal-cost, or technology-displaced names; (5) Special situation — M&A, JV restructuring, regulatory unlocks. Universe spans ~30 names: brine producers, spodumene miners, converters, cathode makers, cell makers, recyclers, iodine and specialty fertilizer producers.

Direction is bidirectional (long + short). Focus name is SQM — global lithium #2, iodine #1, SPN specialty fertilizer leader, with the Codelco JV unlock as the defining catalyst of the cycle.

1.1 Value Screen — Lithium pure-plays at trough multiples

Criteria: EV/EBITDA <8x 2026E, P/B <1.5x, FCF positive at current spot, Net Debt/EBITDA <2.5x. Isolates mean-reversion candidates among scaled, profitable franchises that survived the 2024-2025 price collapse:

SQM screens cheapest among scaled, integrated, FCF-positive lithium franchises with diversification beyond pure-lithium price beta (iodine 35% of EBITDA, SPN specialty fertilizer adds ballast).

1.2 Growth Screen — Emerging producers with capacity ramp

Criteria: Revenue growth >25% expected 2026-2028, capacity expansion under construction or recently commissioned, balance sheet capable of funding ramp without dilution. Captures next-cycle volume leaders:

SGML and PLS pass growth + balance-sheet test cleanly. SQM is not a growth play — it screens as value/quality with embedded reserve-life optionality via the Codelco JV.

1.3 Quality Screen — Lowest cost, highest margin through-cycle

Ranked by 5-year average EBITDA margin, ROIC, and FCF generation including the 2024-2025 trough. Identifies producers that earn through-cycle, not just at peaks:

SQM and Greenbushes (via IGO/ALB/Tianqi) are the global cost-curve floor. SQM's iodine + SPN diversification and Atacama natural-evaporation cost structure produce through-cycle FCF that no peer matches.

1.4 Short Screen — Over-levered, marginal-cost, displacement-risk

Names with asymmetric downside from any combination of: high cost-curve position, balance-sheet strain, deferred capex catching up, technology displacement (sodium-ion / LFP-cathode shift), or governance / accounting opacity:

Short conclusions: We avoid pure short-side conviction in named, single-stock plays beyond Tianqi and a paired ALB hedge. The cleanest short bucket is Chinese lepidolite — operating at top-decile cost — but most exposure is via private operators or non-investable subsidiaries.

1.5 Special Situations — M&A, JV restructuring, regulatory

Named events with discrete catalyst paths and asymmetric payoffs:

• Codelco-SQM JV (target catalyst): New JV (Codelco 50.01% / SQM 49.99%) effective post-2030 extends Atacama Salar lease through 2060, transitions to majority-state structure. Net result: SQM trades reserve-life uncertainty for a longer-dated, lower-share NPV — but unlocks the company's largest valuation overhang. Still subject to indigenous consultation and antitrust review.
• Pilbara Minerals takeout speculation: Persistent rumors (Rio Tinto, Mitsui) for Pilgangoora — clean Tier-1 spodumene at trough valuation. Probability low single-digits but optionality embedded.
• Sigma Lithium takeout: Tesla, Glencore, and Chinese converters all reportedly courted SGML during 2024 lows. Phase 2 funding decision is the trigger.
• LFP cathode vertical integration: Korean and Chinese cell makers building captive lithium offtake; potential strategic premium for SGML or PLS.
• Arcadium / Rio Tinto: Pending RIO acquisition of ALTM at US$5.85/share creates merger-arb spread and read-through to lithium asset values.

2. Thematic Sweep — Lithium Value-Chain Map

We map the global lithium and specialty-chemicals value chain to position SQM correctly within the cycle and identify substitute / complement exposures. Each layer carries different margin profile, cyclicality, and capital intensity.

2.1 Upstream — Brine producers

• SQM (Atacama, Chile) — global #2; lowest-decile cost via natural solar evaporation; reserves to 2030 pre-JV, 2060 post-Codelco JV.
• Albemarle Atacama (Chile) — JV with SQM-adjacent salar; lease expires 2043; second-largest brine producer.
• Arcadium Olaroz (Argentina) — Olaroz brine; expansion under way; Rio Tinto bid in flight.
• Lithium Argentina / Ganfeng Cauchari-Olaroz — Argentine brine; Stage-1 ramping, Stage-2 in design.
• Sub-scale brine: POSCO Hombre Muerto, Lake Resources Kachi, Eramet Centenario — early production / DLE technology pilots.

2.2 Upstream — Spodumene miners

• Greenbushes (WA, Australia) — Tier-1 globally; owned by TLEA (51% Tianqi, 49% IGO/ALB) and ALB direct; lowest spodumene cost worldwide.
• Pilbara Minerals (Pilgangoora) — pure-play, low-end of cost curve, no debt, hydroxide JV with POSCO.
• Mineral Resources (MIN.AX) — Mt Marion + Wodgina; integrated iron ore + lithium; complex capital structure.
• Sigma Lithium (Grota do Cirilo, Brazil) — green spodumene <US$500/t all-in cost; Phase-2 doubles capacity.
• Liontown (Kathleen Valley) — ramp underwhelming; balance-sheet strained.

2.3 Midstream — Lithium converters (carbonate / hydroxide)

• Tianqi Lithium — Sichuan + Kwinana (WA); leveraged from Greenbushes acquisition; opaque accounting.
• Ganfeng Lithium — global #1 converter capacity; weakest 2024 earnings; international expansion writedowns.
• Albemarle conversion — Kemerton (WA), La Negra (Chile), Meishan (China); part of integrated model.
• SQM Carmen Plant + Mt Holland JV (Wesfarmers) — Australia-Chile integrated hydroxide capacity.
• LG Chem, POSCO, EcoPro — Korean converter buildout; downstream-tied via cathode JVs.

2.4 Downstream — Cathodes, cells, EVs

• Cathode makers: LG Chem, POSCO Future M, BTR, Easpring, Ronbay, L&F — pricing pass-through limited; LFP share gains squeeze NCM-focused players.
• Cell makers: CATL (#1), BYD, LG Energy Solution, Samsung SDI, Panasonic, SK On — utilization 60-70%; consolidation likely.
• EV / storage demand: Tesla, BYD, Tesla Megapack, Fluence, Sungrow — battery storage growing >35% CAGR; EV growth 20-25%.
• Recyclers: Redwood Materials (private), Li-Cycle, Glencore — strategic tailwind 2030+ as first EV cohort retires.

2.5 SQM-specific adjacencies — Iodine & Specialty Fertilizer

• Iodine: SQM #1 (~35% global share), Iochem JP, ISE Chemicals JP, Atacama Minerals, Cosayach. Tight market; price stable US$70-80/kg; medical / X-ray / industrial demand resilient. SQM's Nueva Victoria iodine business produces through-cycle margins >50%.
• Specialty fertilizer (SPN): SQM (potassium nitrate global #1), ICL Group (specialty + bromine), Yara International (specialty division), Haifa Group, Compass Minerals. Higher-margin niche within fertilizer; SPN segment provides ballast against lithium volatility.
• Solar salts / lithium bromide / industrial chemicals: ICL bromine, Albemarle bromine, Compass salt — adjacent specialty chains with limited direct lithium read-through.

2.6 Substitution & technology displacement risk

• Sodium-ion: CATL, BYD, HiNa Battery commercializing for short-range EV and stationary storage; structural ceiling on lithium TAM in low-energy-density segments but not a direct EV-grade substitute pre-2030.
• Solid-state batteries: Toyota, QuantumScape, Samsung SDI; lithium-metal anode requires more lithium per kWh, not less — net positive for upstream demand if commercialized.
• LFP cathode share gains: structurally favors lithium carbonate over hydroxide (LFP uses carbonate); favors brine producers (SQM, ALB Atacama) versus integrated hydroxide-skewed converters.
• Direct Lithium Extraction (DLE): Eramet, Lake Resources, ExxonMobil pilots; potentially expands brine resource base by 2030+ but capital-intensive and unproven at scale; not a near-term threat to SQM cost position.

3. Long Ideas

Five long ideas surface from the screens, with SQM as the primary focus. The cohort balances scaled, FCF-generating leaders against high-beta growth optionality:

3.1 SQM — Sociedad Química y Minera (Primary Focus)

• Thesis: Cheapest scaled entry to the lithium recovery cycle with the most defensive cash-flow profile in the cohort. Iodine business (35% of EBITDA, through-cycle margins >50%) and SPN specialty fertilizer (15% of EBITDA) underwrite a base of ~US$1.5B EBITDA even at trough lithium pricing. The Codelco JV — though dilutive on near-term ownership share — extends Atacama reserve life from 2030 to 2060, transforming SQM from a wasting-asset story into a multi-decade royalty franchise.
• Metrics: 2026E revenue US$5.0B, 35% EBITDA margin, US$1.75B EBITDA; 6.7x EV/EBITDA vs 8-10x cycle average; 9% FCF yield; 1.1x ND/EBITDA; lowest-decile lithium cost (US$3-4k/t cash).
• Catalysts: Q1 2026 earnings (May 2026), Codelco JV regulatory milestones (indigenous consultation, antitrust review through 2027), iodine pricing updates, US-China battery trade flow normalization.
• Key risks: Chilean political / royalty risk, lithium oversupply scenario extending below US$12k/t, Codelco JV execution delay, FX (CLP).
• Next steps: Full initiation report (Step 5).

3.2 ALB — Albemarle (Long, Diversified)

• Thesis: Diversified specialty chemicals (lithium + bromine + catalysts), with Greenbushes JV crown jewel as floor under valuation. Lithium capex finally moderating after 2022-2024 buildout cycle, balance sheet capable of weathering lower-for-longer pricing. Trading at 0.95x P/B vs 2.5x five-year average suggests bottom-quintile valuation.
• Metrics: 12x 2026E P/E, 0.95x P/B, 18% EBITDA margin recovering, 2.4x ND/EBITDA, US$5.5B annualized lithium revenue at current spot.
• Catalysts: 2H 2026 lithium price recovery, Kemerton conversion ramp, capex guidance reset, La Negra contract renewals.
• Key risks: Higher cost vs SQM, higher lithium-price beta (no iodine/SPN diversification), Atacama lease expires 2043, Kemerton ramp continues to disappoint.
• Use: Paired comparison to SQM — quantifies SQM's diversification premium and lower lithium beta.

3.3 PLS.AX — Pilbara Minerals (Long, High Beta)

• Thesis: Pure-play Tier-1 spodumene at the lowest end of the Australian cost curve, no debt (US$1.4B net cash), and optionality on integrated lithium hydroxide via the POSCO JV. The cleanest expression of lithium-price recovery in the public market.
• Metrics: A$3.45 = ~6.5x 2027E EV/EBITDA, 34% EBITDA margin at US$14k/t lithium chemicals, 30Mt spodumene reserves at Pilgangoora.
• Catalysts: P680 / P1000 expansion commissioning, POSCO JV hydroxide ramp, takeout speculation (Rio Tinto, Mitsui).
• Key risks: Most levered to lithium spot price (no diversification — no iodine, no bromine, no specialty chems), single-asset (Pilgangoora), AUD/USD.
• Use: High-beta long; allocate as smaller satellite to a SQM core.

3.4 SGML — Sigma Lithium (Long, Small-Cap Optionality)

• Thesis: Brazilian green spodumene producer with Phase-2 capacity expansion approximately doubling output to ~520ktpa. All-in cost <US$500/t, structurally below Australian and Chinese peers. Persistent takeout speculation (Tesla, Glencore, CATL); Phase-2 funding decision is the discrete trigger.
• Metrics: 7x 2027E EV/EBITDA at strip; NPV of Phase-1+2 ~US$5B vs ~US$1B current market cap; net cash position; ~US$330/t cash cost reported Q4 2025.
• Catalysts: Phase-2 financing announcement, takeout offer or strategic partnership, Brazilian regulatory milestones, US/EU tariff frameworks favoring non-Chinese supply.
• Key risks: Single-asset (Grota do Cirilo), Brazilian FX (BRL), regulatory / community relations, founder governance overhang.
• Use: Small-cap satellite with strategic-buyer optionality.

3.5 ICL — ICL Group (Long, Specialty-Fertilizer Comp)

• Thesis: Global specialty-fertilizer leader (potash + bromine + specialty solutions) at trough multiples following 2024 potash price weakness. SQM's closest specialty-fertilizer comp; bromine asset structurally similar to iodine in scarcity profile. Trading at 5.4x EV/EBITDA, 1.05x P/B, with 11% FCF yield.
• Metrics: US$7.0B revenue, 22% EBITDA margin, 1.2x ND/EBITDA, 11% FCF yield.
• Use: SQM specialty-fertilizer read-through; smaller secondary long.

4. Short Ideas

Two named short ideas plus a paired-hedge construct. We avoid broad short conviction in the lithium complex given that most names have already drawn down 50-80% from 2022 highs — fresh shorts require high conviction in continuing operational deterioration or balance-sheet strain.

4.1 Tianqi Lithium (9696.HK / 002466.SZ) — Short

• Thesis: Over-levered acquisition of Greenbushes (TLEA) leaves Tianqi with ND/EBITDA >4x and limited deleveraging path absent equity issuance. Accounting opacity (treatment of Kwinana ramp losses, IGO interest in TLEA, Chinese GAAP reconciliation) presents asymmetric downside if disclosure tightens. Limited proprietary technology IP versus Ganfeng. Equity dilution risk in 2027 if lithium prices remain below US$15k/t.
• Metrics: 4.2x Net Debt/EBITDA, P/B 1.2x but stale book given Kwinana write-down risk, 2024 net loss, China policy and FX overhang.
• Catalysts: 2026 covenant tests, Kwinana ramp updates, IGO put/call mechanics on TLEA stake, equity issuance announcement.
• Key risks (against short): Greenbushes commodity exposure could rally on China stimulus, Chinese government strategic-asset support, short-squeeze risk in less-liquid HK/SZ shares.
• Implementation note: Cross-listing constraints — preferred via HK 9696 for liquidity and offshore custody.

4.2 Albemarle (ALB) — Paired Short vs SQM Long

• Thesis: Use as paired short to isolate SQM's company-specific alpha (iodine + SPN + Codelco JV + lower cost) from broader lithium-price beta. ALB's higher cost structure, higher leverage (2.4x vs SQM 1.1x), and absence of non-lithium diversification mean ALB underperforms in any continuation of the lithium-trough scenario, even if SQM appreciates on idiosyncratic catalysts.
• Metrics: 12x 2026E P/E vs SQM 11x; 18% EBITDA margin vs SQM 35%; 2.4x ND/EBITDA vs SQM 1.1x.
• Use: Hedge for the SQM long — sizes SQM exposure on company-specific factors rather than absolute lithium-price view.

4.3 Lepidolite producers (China) — Short basket (limited investability)

• Thesis: Top-decile cost producers in Yichun (Jiangxi) and other Chinese lepidolite regions operate at US$10-12k/t cash cost — first to shut in any continuation of trough pricing. Many are private, non-investable, or subsidiaries of larger groups.
• Implementation: Practical exposure limited; mostly relevant as a fundamental input to the lithium price floor thesis rather than a tradable short.

5. Neutral / Watchlist

Names monitored but not yet sized. Each is either too tactical for current cycle position, lacks differentiation versus core picks, or has structural concerns that warrant pass:

5.1 Mosaic (MOS) — Neutral

• Watchlist: phosphate cycle exposure and Brazilian operations; specialty fertilizer overlap with SQM SPN is modest. Not direct read-through to SQM thesis.

5.2 ICL Group (ICL) — Long (covered above), but capped position

• Bromine is the structurally interesting asset (iodine analog), but potash exposure is a drag; cap position size accordingly.

5.3 Liontown Resources (LTR.AX) — Underperform

• Capital structure stretched, Kathleen Valley project ramp-up disappointing, refinancing risk on the convertible. Not a clean short due to takeout-floor potential, not a long because of execution risk. Pass.

5.4 Ganfeng Lithium (002460.SZ) — Underperform

• Worst earnings of major converters, Chinese policy headwinds, sub-scale international assets with continuing writedown risk. Avoid both directions until 2026 results clarify margin trajectory.

5.5 Arcadium Lithium (ALTM) — Special Situation, Closed

• Pending Rio Tinto acquisition at US$5.85/share. Merger arbitrage spread tight; not a position but watch for deal completion and read-through to private lithium asset values.

6. Comparison Table — All Ideas

7. Priority List & Next Steps

• Priority 1 — SQM (Long): Proceed to full initiation this cycle. Cheapest scaled lithium franchise with through-cycle FCF underwritten by iodine and SPN, plus the Codelco JV multi-decade reserve unlock as defining catalyst. Full pipeline (comps, DCF, 3-statements, initiation report) anchors here.
• Priority 2 — ALB (Long / Paired Short): Build paired comparison to SQM. Quantifies SQM's diversification premium and lithium-beta sensitivity. Use as hedge sleeve to isolate SQM company-specific alpha.
• Priority 3 — PLS.AX (Long, High Beta): Deeper dive scheduled for Q2. Pure-play Tier-1 spodumene with optionality. Allocate as smaller satellite to SQM core after fundamental review.
• Priority 4 — SGML (Long, Small Cap): Q3 deep-dive on takeout-story merits. Single-asset risk + Brazilian FX warrants smaller sizing; strategic-buyer optionality embedded.
• Priority 5 — Tianqi (Short): Cross-listing implementation constraints (preferred via HK 9696). Track 2026 covenant tests and Kwinana ramp updates. Initiate when leverage signal triggers.
• Watchlist (no immediate action): ICL, MOS, LTR.AX, 002460. Re-screen after H1 2026 reporting.

8. Sources & Methodology Notes

Quantitative screens drawn from public filings (10-K, 10-Q, 6-K, ASX/HKEX disclosures), Bloomberg consensus estimates, and company investor presentations as of April 2026. Lithium pricing references: Fastmarkets, Benchmark Mineral Intelligence, S&P Global Platts (carbonate CIF China, hydroxide CIF China, spodumene 6% CIF China). Cost-curve positioning derived from company disclosures, sell-side mining notes, and CRU/Wood Mackenzie cost-curve studies (2024-2025 vintage).

Codelco-SQM JV terms: 50.01% Codelco / 49.99% SQM ownership effective post-2030; lease extended through 2060; subject to indigenous consultation, antitrust review, and final closing conditions. Source: Joint communique (May 2024), SQM 6-K filings, Codelco corporate disclosures.

Iodine market shares and end-use breakdown: SQM corporate sustainability report, IODL trade data, USGS Mineral Commodity Summaries 2025.

Specialty fertilizer / SPN market: SQM segment disclosures, Yara investor presentations, Argus FMB Specialty Fertilizers benchmarks.

DISCLAIMER: This report was produced by an agentic AI workflow (Agentic Finance Chile) for research and educational purposes. Data current to Apr 2026. Not investment advice.